Sign in
Enrolling by invitationNo phase

Study the Mechanism and Effectiveness of Probiotics on Atopic Dermatitis

Key facts

Who runs it
National Cheng-Kung University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
90 people, planned
Started
30 Jun 2026
Expected to end
31 Dec 2030
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Probiotic 2 × 10^8
  • Placebo capsule
  • Probiotic 2 × 10^10
Record updated
16 November 2026

Who can take part

Age
3 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Aged 3 to 18 years
  • Diagnosis of atopic dermatitis with moderate-to-severe disease, defined as an Eczema Area and Severity Index (EASI) score > 7 at screening
  • Receiving regular atopic dermatitis treatment at National Cheng Kung University Hospital
  • Written informed consent from the participant's legal representative, with assent from participants aged 7 years and older

Who cannot take part

  • Current or planned treatment with a biologic agent (e.g., dupilumab, an anti-IL-4Rα antibody)
  • Current or planned treatment with an oral small-molecule immunosuppressant (e.g., upadacitinib)
  • Skin disease other than atopic dermatitis

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 3 and 18 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn whether probiotics isolated from breast milk and healthy infant feces can reduce the severity of atopic dermatitis (eczema) in children aged 3 to 18 years with moderate-to-severe disease. The main questions it aims to answer are:

Read full original descriptionShow less

* Does taking the probiotic capsule twice daily for 12 weeks reduce eczema severity, measured by the EASI SCORAD? * Does the probiotic improve quality of life, blood markers of allergic inflammation (IgE, histamine, IL-31, T-cell subsets), and gut microbiota composition? Researchers will compare the probiotic to a placebo capsule that looks the same but contains no probiotic bacteria.

Participants will:

* Take one capsule twice daily for 12 weeks, in addition to their usual atopic dermatitis treatment * Complete the PO-SCORAD and a quality-of-life questionnaire at baseline and weeks 2, 4, 8 and 12 * Provide stool samples at baseline and weeks 4 and 12, and a 10 mL blood sample at baseline and week 12.

The 3 groups in the trial

  • Probiotic 2*10^8Treatment being tested

    One probiotic(2\*10\^8) twice daily for 12 weeks, in addition to regular atopic dermatitis treatment.

  • Probiotic 2*10^10Treatment being tested

    One probiotic(2\*10\^10) twice daily for 12 weeks, in addition to regular atopic dermatitis treatment.

  • PlaceboPlacebo, for comparison

    One identical-appearing placebo capsule twice daily for 12 weeks, in addition to regular atopic dermatitis treatment.

    Treatment: Placebo capsule

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Revolutionary Concept of X-biotics for Correcting Disease-associated Microbiota Compositions: Focus on Atopic, Gastrointestinal, Neurological, and Metabolic Disease: Study the Mechanism and Effectiveness of Probiotics on Atopic Dermatitis
Criteria questions
Built from NCT07937592, who can take part
Record updated
16 November 2026